Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ERAS-007 +/- ERAS-601 in Advanced Solid Tumors
NCT04866134Phase 2Completed
- Sponsor
- Erasca
- Start
- May 2021
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ERAS-007 in solid tumor, sponsored by Erasca. Started May 2021; status: completed.
02
Drugs
ERAS-007
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04866134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04866134.